• Login
Monday, May 4, 2026
Geneva Times
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
Geneva Times
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
Home Business

Abu Dhabi launches life science cluster as it targets $25.6bn GDP injection and 30,000 health jobs

GenevaTimes by GenevaTimes
April 16, 2025
in Business
Reading Time: 3 mins read
0
Abu Dhabi launches life science cluster as it targets .6bn GDP injection and 30,000 health jobs
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter


Abu Dhabi has launched a groundbreaking life sciences cluster, reinforcing its position as a global hub for biotechnology, MedTech, and digital health.

Developed by the Abu Dhabi Department of Economic Development, Abu Dhabi Investment Office (ADIO) and the Department of Health – Abu Dhabi, the Health, Endurance, Longevity, and Medicine (HELM) cluster is designed to drive healthcare innovation, attract international investment, and deliver lasting benefits to global populations.

By 2045, the HELM cluster is expected to contribute $25.6bn (AED94bn) to Abu Dhabi’s GDP, attract $11.5bn (AED42bn) in investment, and create 30,000 high-value jobs, supporting the diversification of the emirate’s economy while enabling long-term global health impact.

Abu Dhabi Health, Endurance, Longevity, and Medicine cluster

Announced during Abu Dhabi Global Health Week, the HELM cluster will serve as a platform for the research, development, manufacturing and commercialisation of advanced health and life science solutions.

From AI-powered diagnostics and pharmaceutical manufacturing to gene therapies and precision medicine, the cluster is poised to enable global companies to transform breakthrough science into scalable and accessible, patient-focused solutions.

With its world-class infrastructure, progressive regulations, and strategic geographic location, Abu Dhabi offers unparalleled access to global markets.

The emirate’s multicultural talent base, advanced biomanufacturing facilities, and commitment to innovation make it an ideal launchpad for life sciences companies looking to scale globally.

Ahmed Jasim Al Zaabi, Chairman of the Department of Economic Development, said: “The Abu Dhabi Health, Endurance, Longevity, and Medicine (HELM) cluster will provide global and local stakeholders with a wide range of benefits, including access to cutting-edge technologies, world-class infrastructure and progressive regulatory frameworks.

“By creating a globally competitive life sciences hub, we are not only accelerating economic growth and diversification, but we are also ensuring that Abu Dhabi remains at the forefront of developing breakthrough healthcare solutions that will benefit humanity at large.”

Built to meet the rising global demand for advanced healthcare, the cluster is designed to tackle some of the world’s most pressing health challenges, including chronic and non-communicable diseases, which account for more than 70 per cent of deaths globally, as well as the healthcare needs of ageing populations.

It is tapping growth opportunities in the global healthcare market, which is projected to reach $25.3tn (AED93tn) by 2045.

Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi, said: “The launch of Abu Dhabi’s Health, Endurance, Longevity, and Medicine cluster is a bold leap forward in how the world delivers healthcare.

“We are not just investing in infrastructure, we’re investing in human potential, in breakthroughs that will redefine longevity, and in solutions that will reach far beyond our borders. This is where innovation meets impact.”

Leveraging an innovation-friendly regulatory framework, Abu Dhabi empowers companies to bring breakthrough technologies to market faster, shaping the future of healthcare at speed and scale.

Its AI-powered health system and leadership in precision medicine create an environment where innovation thrives across the entire value chain.

As home to one of the world’s largest national genomics programme, the emirate supports research and development by fostering insights from a uniquely diverse genomic landscape, accelerating innovation and advancing the global shift toward personalised treatments.

At the same time, Abu Dhabi is strengthening its role in the global pharmaceutical supply chain, offering reliable infrastructure, strategic connectivity, and long-term partnership opportunities for companies navigating an increasingly complex global landscape.

The cluster is part of Abu Dhabi’s broader strategy to lead globally in emerging industries. It follows the successful launch of:

  • The Smart and Autonomous Vehicle Industries (SAVI) cluster in 2023, which addresses smart urban mobility across air, land, and sea
  • The AgriFood Growth and Water Abundance (AGWA) cluster in 2024, which addresses food security and water sustainability challenges

Read More

Previous Post

US judge rules he could hold Trump administration in contempt

Next Post

Ukrainian civil society in wartime

Next Post
Ukrainian civil society in wartime

Ukrainian civil society in wartime

ADVERTISEMENT
Facebook Twitter Instagram Youtube LinkedIn

Explore the Geneva Times

  • About us
  • Contact us

Contact us:

editor@thegenevatimes.ch

Visit us

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin